Vanguard Capital Management
TIL icon

Vanguard Capital Management’s Instil Bio TIL Stock Holding History

Vanguard Capital Management’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26M Sell
163,738
-10,845
-6% -$87.5K ﹤0.01% 3547
2026
Q1 		$1.44M Buy
+174,583
New +$1.42M ﹤0.01% 3470

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $14.6M AUM 63.08% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $140M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Vanguard Capital Management's TIL Position: Q2 2026 in Review

Vanguard Capital Management reduced its Instil Bio (TIL) stake by 6.2% in Q2 2026, selling an estimated $87.5K and leaving 163,738 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #3547.

Vanguard Capital Management first reported a position in TIL in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.44M in Q1 2026. 24 funds tracked by Wall St. Rank hold TIL as of Q2 2026.

  • Vanguard Capital Management held 163,738 shares of Instil Bio worth $1.26M as of Q2 2026.
  • Vanguard Capital Management sold 10,845 Instil Bio shares in Q2 2026, an estimated $87.5K.
  • Instil Bio made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3547 holding.
  • Vanguard Capital Management first reported a position in Instil Bio in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Capital Management's Instil Bio position peaked at $1.44M in Q1 2026.
  • 24 funds tracked by Wall St. Rank held Instil Bio as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.